Navigation Links
China Pharma Events Attract Over 27,000 Visitors
Date:7/12/2011

AMSTERDAM, July 12, 2011 /PRNewswire/ -- Leading events organiser UBM Live , a division of UBM Plc (LSE: UBM), announced that its pharmaceutical ingredients event, CPhI China 2011 and co-located events ICSE China for contract and outsourced services, P-MEC China for pharmaceutical machinery and equipment and BioPh China to cater to the biopharmaceuticals market, held from June 21st to 23rd at the SNIEC in Shanghai, experienced a 36% increase in attendance from the 2010 events. Over three days, ten exhibition halls and 4,500 square meters of temporary exhibition space were prepared to host a record of 27,198 attendees, including 5,479 international visitors. Exhibitor numbers also rose year over year. Together, the CPhI China, ICSE China and BioPh China events hosted 1,518 exhibitors, while P-MEC China and the newly introduced LABWorld pavilion for lab instrumentation and analysis hosted 386 exhibitors.

"The growth of CPhI China and the co-located events reflects the transitions in the global marketplace. China has experienced exceptional growth and is expected to overtake Japan and become the world's second drug market by 2015 with an estimated value of $100B(1). The events offer a high quality platform for both exhibitors and visitors to have direct access to a comprehensive audience in the local Chinese and global pharmaceutical markets," Annemieke Timmers, Brand Director for CPhI Events said. "During the planning of these events, we remained focused on the market and our customer feedback. We are pleased that the line-up was so well received and look forward to returning to China in 2012."

New event features were offered and established events experienced growth in 2011. The newly launched ICSE China pavilion covered 1,000 square meters of space where 70 exhibitors dedicated to pharma outsourcing and contract services suppliers were located. P-MEC China returned for its third year with an expansion in size to 14,067 square meters and the introduction of the LABWorld China pavilion to offer resources for laboratory, analytical and biotechnological equipment.  

"We are delighted with the continued growth of the brands in China, particularly the increasingly international mix of visitors," commented Haf Cennydd, Brand Director for ICSE, P-MEC, LABWorld and BioPh. "We continuously look to evolve the brands so that our visitors and exhibitors have ample opportunities to maximize their return on investment in attending. Features such as the newly introduced conference series are constantly being developed as a complimentary resource to our guests."

The inaugural China conference series, titled "Pharma R&D and Collaboration Strategies", addressed global pharmaceutical issues, with an emphasis on China's pharma market, across key areas such as New Drug Discovery, Biopharm, Biosimilars, CRO/CMO, API Sourcing, Generics and Export Strategies and more. Thirty eminent speakers from international pharmaceutical companies and research institutes, such as the FDA, Novartis, USP-China, Roche R&D Center, GSK China/HK, AstraZeneca Innovation Centre China, Sanofi-Aventis, Reva Pharma, Dr. Reddy's and  Shanghai Pharma, shared their knowledge and research strategies.

For more information about CPhI China (26-28 June, 2012, SNIEC, Shanghai, China), please visit: www.cphi-china.com.

The UBM Live annual schedule of pharma events also includes, Japan (13-15, July, Intex Osaka Exhibition Centre, Japan), South America (25-26, August, Transamerica Expo Centre, Sao Paulo, Brazil 2011), Worldwide (25-27, October, Messe Frankfurt, Germany 2011), and India (30 November – 2 December, 2011, Bombay Exhibition Centre, Mumbai, India).

(1) ARC China December 4, 2010 Newsletter

Notes for Editors:

UBM Live is a division of UBM Plc (LSE: UBM) a leading provider of business information services to the maritime, travel, fashion, technology, healthcare, media, and property industries. UBM offers services in trade shows, online, news distribution, and publishing to customers across the globe. Its brands are represented in more than 30 countries and are organized into specialist teams that serve their business communities helping them excel in their market by working effectively and efficiently. For more information, go to www.ubmlive.com.


'/>"/>
SOURCE UBM Live
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. China Medicine Corporation to Restate Financial Statements for 2006 and 2007
2. Lithotripters Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
3. China Botanic Pharmaceutical Granted China Patent for Siberian Ginseng Extraction Process
4. China Grants COPAN Patent for Flocked Swabs
5. Golden Meditech to Increase Stake in NYSE-listed Affiliate -- China Cord Blood Corporation to 39.5%
6. Reportlinker Adds The Outlook for Medical Devices in Brazil, Russia, India & China
7. Winner Medical to Present at Brean Murray, Carret & Co. Beijing China Growth Conference
8. China Medical Technologies Announces Strategic Collaboration Between its Subsidiary, GP Medical, and Da An Health
9. Chinmax Disclaims Liability Following China SFDAs Confirmation that Inverness Medical Beijing is Suspected of Forging SFDA Verification Seal and Approval Date in Submission of Triage BNP Test Registration
10. Nutrastar to Participate in Brean Murray, Carret & Co.s 2011 Beijing China Growth Conference
11. Access Pharmaceuticals Receives Letter of Acceptance For MuGard Filing From SFDA of China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... Research and Markets has announced the addition ... Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, Binder, ... Forecast to 2021" report to their offering. ... excipients market is projected to reach USD 8.1 Billion ... forecast period 2016 to 2021. The ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) ... held on June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, ... dedicated to helping service members that have been wounded in battle and their families. ...
(Date:6/24/2016)... ... 2016 , ... Finally, a bruise cream that really works. Originally designed ... into the post-surgical treatment plans of a variety of other procedures including, but not ... effective for bruising and causes a rapid resolution of bruising and inflammatory changes compared ...
(Date:6/24/2016)... ... 24, 2016 , ... Today, InhaleLabs.com (Inhale) offilially launched its site, ... matching users with high quality water pipes within an ideal price range. The site ... was founded by two brothers, Nick and Mike Hunter, who use medical cannabis to ...
(Date:6/23/2016)... ... June 23, 2016 , ... Terumo BCT, ... organization responsible for clinical transfusion research programs and for the blood supply in ... Evaluation and Predictive Analytical Rating Score (PREPAReS) study. , Currently in its ...
(Date:6/23/2016)... ... June 23, 2016 , ... The Mechille Wilson Agency, ... throughout Jasper County and the surrounding region, is initiating a charity drive to assist ... raise funds earmarked for a scholarship fund that will be presented to the chosen ...
Breaking Medicine News(10 mins):